The Supreme Court has issued a ruling that will allow the abortion drug mifepristone to remain in circulation, declaring that a legal challenge against the FDA had no standing, according to a report by Fox News:
“In a victory for the Biden administration and abortion rights supporters, the high court gave a unanimous decision that challengers to the FDA lacked standing to sue the government.
“‘Under Article III of the Constitution, a plaintiff’s desire to make a drug less available for others does not establish standing to sue. Nor do the plaintiffs’ other standing theories suffice,’ Justice Brett Kavanaugh writes.
“In March, the justices heard about 90 minutes of arguments about federal government regulations since 2016 that made access to mifepristone easier, including access by mail.
“In overturning Roe v. Wade in June 2022, the Supreme Court ruled in Dobbs v. Jackson Women’s Health Organization that the U.S. Constitution does not guarantee the right to an abortion and that the matter may be decided by the states.
“In the aftermath, 14 states have banned abortion at all stages of pregnancy, with some exceptions, and two others have banned abortion once a fetal heartbeat is detected, which is at around six weeks of gestation.”
To read the entire article by Fox News, please click HERE.
